Agiliti, Inc. (NYSE:AGTI – Get Rating) CFO James B. Pekarek sold 14,668 shares of the company’s stock in a transaction that occurred on Monday, March 13th. The shares were sold at an average price of $15.03, for a total value of $220,460.04. Following the completion of the transaction, the chief financial officer now directly owns 249,071 shares of the company’s stock, valued at $3,743,537.13. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Agiliti Price Performance
Shares of NYSE AGTI opened at $14.92 on Wednesday. The stock has a fifty day simple moving average of $17.72 and a two-hundred day simple moving average of $16.95. Agiliti, Inc. has a 1-year low of $14.15 and a 1-year high of $23.25. The firm has a market cap of $2.00 billion, a price-to-earnings ratio of 71.05, a price-to-earnings-growth ratio of 16.39 and a beta of 1.40. The company has a current ratio of 1.60, a quick ratio of 1.25 and a debt-to-equity ratio of 1.14.
Hedge Funds Weigh In On Agiliti
Several institutional investors and hedge funds have recently bought and sold shares of the company. Wells Fargo & Company MN boosted its holdings in shares of Agiliti by 180.8% in the fourth quarter. Wells Fargo & Company MN now owns 1,536 shares of the company’s stock worth $25,000 after acquiring an additional 989 shares during the period. Macquarie Group Ltd. bought a new position in shares of Agiliti in the second quarter worth $28,000. Group One Trading L.P. bought a new position in shares of Agiliti in the fourth quarter worth $31,000. Clear Street Markets LLC bought a new position in shares of Agiliti in the fourth quarter worth $40,000. Finally, Dark Forest Capital Management LP bought a new position in shares of Agiliti in the second quarter worth $99,000.
Analysts Set New Price Targets
Agiliti, Inc provides end-to-end healthcare technology management and service solutions to the United States healthcare industry. It also offers comprehensive medical equipment management and service solutions to reduce capital and operating expenses, increase medical equipment and staff productivity and support improved patient safety and outcomes.
- Get a free copy of the StockNews.com research report on Agiliti (AGTI)
- Monoclonal Antibodies? Avid Bioservices surges 32% on Blowout Q3
- GitLab Crashes On Guidance; Analysts Defend
- Healthcare Stocks With at Least 30 Years of Dividend Increases
- Coinbase Pops As SVB Crumbles To Dust
- Airlines Update Guidance, Shares Head For Different Destinations
Receive News & Ratings for Agiliti Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agiliti and related companies with MarketBeat.com's FREE daily email newsletter.